Global Downstream Process Development Service 麻豆原创 Research Report 2024

Publication ID:

PB512243286

Publication Date:

December 31, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Downstream Process Development Service was valued at US$ 726 million in the year 2023 and is projected to reach a revised size of US$ 927 million by 2030, growing at a CAGR of 3.8% during the forecast period.
Downstream Process Development Service is a professional service for biopharmaceutical products, focusing on optimizing the downstream process of separating and purifying the target product from cell culture fluid or raw materials during the production process. This service ensures the purity, safety and biological activity of the target product by developing and verifying efficient separation and purification strategies (such as precipitation, filtration, chromatography and concentration, etc.), while complying with industry regulations and quality requirements. Downstream process development services run through all stages from drug research and development to commercialization, and are one of the key links in the production process of biopharmaceuticals.
North American market for Downstream Process Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Downstream Process Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Downstream Process Development Service in Antibody Drugs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Downstream Process Development Service include Isomerase, Richter BioLogics, Scorpius, Northway Biotech, Curia, ExcellGene SA, FyoniBio, BOC Sciences, Bioentia, Rentschler Biopharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Downstream Process Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Downstream Process Development Service.
The Downstream Process Development Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Downstream Process Development Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Downstream Process Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Isomerase
Richter BioLogics
Scorpius
Northway Biotech
Curia
ExcellGene SA
FyoniBio
BOC Sciences
Bioentia
Rentschler Biopharma
VIVEbiotech
Kemp Proteins
Segment by Type
Purification Process Development
Separation Process Development
Others
Segment by Application
Antibody Drugs
Recombinant Proteins
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Downstream Process Development Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Downstream Process Development Service 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Purification Process Development
1.2.3 Separation Process Development
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Downstream Process Development Service 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Antibody Drugs
1.3.3 Recombinant Proteins
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Downstream Process Development Service 麻豆原创 Perspective (2019-2030)
2.2 Global Downstream Process Development Service Growth Trends by Region
2.2.1 Global Downstream Process Development Service 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Downstream Process Development Service Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Downstream Process Development Service Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Downstream Process Development Service 麻豆原创 Dynamics
2.3.1 Downstream Process Development Service Industry Trends
2.3.2 Downstream Process Development Service 麻豆原创 Drivers
2.3.3 Downstream Process Development Service 麻豆原创 Challenges
2.3.4 Downstream Process Development Service 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Downstream Process Development Service Players by Revenue
3.1.1 Global Top Downstream Process Development Service Players by Revenue (2019-2024)
3.1.2 Global Downstream Process Development Service Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Downstream Process Development Service 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Downstream Process Development Service Revenue
3.4 Global Downstream Process Development Service 麻豆原创 Concentration Ratio
3.4.1 Global Downstream Process Development Service 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Downstream Process Development Service Revenue in 2023
3.5 Global Key Players of Downstream Process Development Service Head office and Area Served
3.6 Global Key Players of Downstream Process Development Service, Product and Application
3.7 Global Key Players of Downstream Process Development Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Downstream Process Development Service Breakdown Data by Type
4.1 Global Downstream Process Development Service Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Downstream Process Development Service Forecasted 麻豆原创 Size by Type (2025-2030)
5 Downstream Process Development Service Breakdown Data by Application
5.1 Global Downstream Process Development Service Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Downstream Process Development Service Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Downstream Process Development Service 麻豆原创 Size (2019-2030)
6.2 North America Downstream Process Development Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Downstream Process Development Service 麻豆原创 Size by Country (2019-2024)
6.4 North America Downstream Process Development Service 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Downstream Process Development Service 麻豆原创 Size (2019-2030)
7.2 Europe Downstream Process Development Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Downstream Process Development Service 麻豆原创 Size by Country (2019-2024)
7.4 Europe Downstream Process Development Service 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Downstream Process Development Service 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Downstream Process Development Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Downstream Process Development Service 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Downstream Process Development Service 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Downstream Process Development Service 麻豆原创 Size (2019-2030)
9.2 Latin America Downstream Process Development Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Downstream Process Development Service 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Downstream Process Development Service 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Downstream Process Development Service 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Downstream Process Development Service 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Downstream Process Development Service 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Downstream Process Development Service 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Isomerase
11.1.1 Isomerase Company Details
11.1.2 Isomerase Business Overview
11.1.3 Isomerase Downstream Process Development Service Introduction
11.1.4 Isomerase Revenue in Downstream Process Development Service Business (2019-2024)
11.1.5 Isomerase Recent Development
11.2 Richter BioLogics
11.2.1 Richter BioLogics Company Details
11.2.2 Richter BioLogics Business Overview
11.2.3 Richter BioLogics Downstream Process Development Service Introduction
11.2.4 Richter BioLogics Revenue in Downstream Process Development Service Business (2019-2024)
11.2.5 Richter BioLogics Recent Development
11.3 Scorpius
11.3.1 Scorpius Company Details
11.3.2 Scorpius Business Overview
11.3.3 Scorpius Downstream Process Development Service Introduction
11.3.4 Scorpius Revenue in Downstream Process Development Service Business (2019-2024)
11.3.5 Scorpius Recent Development
11.4 Northway Biotech
11.4.1 Northway Biotech Company Details
11.4.2 Northway Biotech Business Overview
11.4.3 Northway Biotech Downstream Process Development Service Introduction
11.4.4 Northway Biotech Revenue in Downstream Process Development Service Business (2019-2024)
11.4.5 Northway Biotech Recent Development
11.5 Curia
11.5.1 Curia Company Details
11.5.2 Curia Business Overview
11.5.3 Curia Downstream Process Development Service Introduction
11.5.4 Curia Revenue in Downstream Process Development Service Business (2019-2024)
11.5.5 Curia Recent Development
11.6 ExcellGene SA
11.6.1 ExcellGene SA Company Details
11.6.2 ExcellGene SA Business Overview
11.6.3 ExcellGene SA Downstream Process Development Service Introduction
11.6.4 ExcellGene SA Revenue in Downstream Process Development Service Business (2019-2024)
11.6.5 ExcellGene SA Recent Development
11.7 FyoniBio
11.7.1 FyoniBio Company Details
11.7.2 FyoniBio Business Overview
11.7.3 FyoniBio Downstream Process Development Service Introduction
11.7.4 FyoniBio Revenue in Downstream Process Development Service Business (2019-2024)
11.7.5 FyoniBio Recent Development
11.8 BOC Sciences
11.8.1 BOC Sciences Company Details
11.8.2 BOC Sciences Business Overview
11.8.3 BOC Sciences Downstream Process Development Service Introduction
11.8.4 BOC Sciences Revenue in Downstream Process Development Service Business (2019-2024)
11.8.5 BOC Sciences Recent Development
11.9 Bioentia
11.9.1 Bioentia Company Details
11.9.2 Bioentia Business Overview
11.9.3 Bioentia Downstream Process Development Service Introduction
11.9.4 Bioentia Revenue in Downstream Process Development Service Business (2019-2024)
11.9.5 Bioentia Recent Development
11.10 Rentschler Biopharma
11.10.1 Rentschler Biopharma Company Details
11.10.2 Rentschler Biopharma Business Overview
11.10.3 Rentschler Biopharma Downstream Process Development Service Introduction
11.10.4 Rentschler Biopharma Revenue in Downstream Process Development Service Business (2019-2024)
11.10.5 Rentschler Biopharma Recent Development
11.11 VIVEbiotech
11.11.1 VIVEbiotech Company Details
11.11.2 VIVEbiotech Business Overview
11.11.3 VIVEbiotech Downstream Process Development Service Introduction
11.11.4 VIVEbiotech Revenue in Downstream Process Development Service Business (2019-2024)
11.11.5 VIVEbiotech Recent Development
11.12 Kemp Proteins
11.12.1 Kemp Proteins Company Details
11.12.2 Kemp Proteins Business Overview
11.12.3 Kemp Proteins Downstream Process Development Service Introduction
11.12.4 Kemp Proteins Revenue in Downstream Process Development Service Business (2019-2024)
11.12.5 Kemp Proteins Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Isomerase
Richter BioLogics
Scorpius
Northway Biotech
Curia
ExcellGene SA
FyoniBio
BOC Sciences
Bioentia
Rentschler Biopharma
VIVEbiotech
Kemp Proteins

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.